Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: A post-mortem study

Journal of Neural Transmission

Volumn 116, Issue 12, 2009, Pages 1657-1665

  Habl, Gregor ^a,b   Zink, Mathias ^a   Petroianu, Georg ^c   Bauer, Manfred ^e   Schneider Axmann, Thomas ^f   Von Wilmsdorff, Martina ^g   Falkai, Peter ^f   Henn, Fritz A ^a,d   Schmitt, Andrea ^a,f  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

DAAO; Gene expression; Hippocampus; In situ hybridization; Schizophrenia

Indexed keywords

DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DAAO GENE; ENTORHINAL CORTEX; FEMALE; FRONTAL CORTEX; GENE; GENE EXPRESSION PROFILING; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SENSORY CORTEX; TEMPORAL CORTEX; THALAMUS; THALAMUS DORSOMEDIAL NUCLEUS; WHITE MATTER;

AGED; CEREBRAL CORTEX; D-AMINO-ACID OXIDASE; DENTATE GYRUS; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MALE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; RNA, MESSENGER; SCHIZOPHRENIA; THALAMUS;

EID: 70949107578     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0312-z     Document Type: Article

References (44)

1. T Adage AC Trillat A Quattropani D Perrin L Cavarec J Shaw O Guerassimenko C Giachetti B Greco I Chumakov S Halazy A Roach P Zaratin 2008 In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties Eur Neuropsychopharmacol 18 3 200 214 10.1016/j.euroneuro.2007.06.006 1:CAS:528:DC%2BD1cXosFGltA%3D%3D 17681761
2. Amaral D, Lavanex P (2007) Hippocampal neuroanatomy. In: Andersen P, Morris R, Amaral D, Bliss T, O′Keefe J (eds) The hippocampal book. Oxford University Press, NY, pp 37-114
3. American PA (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
4. I Bendikov C Nadri S Amar R Panizzutti J DeMiranda H Wolosker G Agam 2007 A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia Schizophr Res 90 41 51 10.1016/j.schres.2006.10.010 17156977 (Pubitemid 46177566)
5. B Bogerts 1997 The temporolymbic system theory of positive schizophrenic symptoms Schizophr Bull 23 423 435 1:STN:280:DyaK2svmvVChsg%3D%3D 9327507
6. B Bogerts P Falkai M Haupts B Greve S Ernst U Tapernon-Franz U Heinzmann 1990 Post-mortem volume measurements of limbic system and basal ganglia structures in chronic chizophrenics. Initial results from a new brain collection Schizophr Res 3 295 301 10.1016/0920-9964(90)90013-W 1:STN:280: DyaK3M7ivFWgtg%3D%3D 2282334 (Pubitemid 20383963)
7. B Bogerts JA Lieberman M Ashtari RM Bilder G Degreef G Lerner C Johns S Masiar 1993 Hippocampua-amygdala volumes and psychopathology in chronic schizophrenia Biol Psychiatry 33 236 246 10.1016/0006-3223(93)90289-P 1:STN:280:DyaK3s3ivFKjtA%3D%3D 8471676 (Pubitemid 23091498)
8. H Braak E Braak 1991 Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 4 239 259 10.1007/BF00308809 1:STN:280: DyaK387gtFOiug%3D%3D 1759558
9. H Braak I Alafuzoff T Arzberger H Kretzschmar K Del Tredici 2006 Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol 112 4 389 404 10.1007/s00401-006-0127-z 16906426 (Pubitemid 44469160)
10. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):IV37-IV/43
11. I Chumakov M Blumenfeld O Guerassimenko L Cavarec M Palicio H Abderrahim L Bouguelleret C Barry H Tanaka P La Rosa 2002 Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid ocidase in schizophrenia Proc Natl Acad Sci USA 99 13675 13680 10.1073/pnas.182412499 1:CAS:528:DC%2BD38XotVKmtrk%3D 12364586 (Pubitemid 35215440)
12. A Corvin G Donohoe K McGhee K Murphy N Kenny S Schwaiger JM Nangle D Morris M Gill 2007 d-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia Neurosci Lett 426 2 97 100 10.1016/j.neulet.2007.09.002 1:CAS:528:DC%2BD2sXhtFWiurnI 17890006 (Pubitemid 47464716)
13. JT Coyle 1996 The glutamatergic dysfunction hypothesis for schizophrenia Harv Rev Psychiatry 3 5 241 253 10.3109/10673229609017192 1:STN:280: DyaK1c%2Fjs1yktQ%3D%3D 9384954
14. E Dawson E Parfitt Q Roberts J Daniels L Lim P Sham M Nothen P Propping M Lanczik W Maier 1995 Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1 Am J Med Genet 60 94 102 10.1002/ajmg.1320600203 1:STN:280:DyaK28%2FptVahtw%3D%3D 7485258
15. SD Detera-Wadleigh FJ McMahon 2006 G72/G30 in Schizophrenia and bipolar disorder: review and meta-analysis Biol Psychiatry 60 2 106 114 10.1016/j.biopsych.2006.01.019 1:CAS:528:DC%2BD28Xmsl2jtbY%3D 16581030 (Pubitemid 44026593)
16. TE Goldberg RE Straub JH Callicott A Hariri VS Mattay L Bigelow R Coppola MF Egan DR Weinberger 2006 The G72/G30 gene complex and cognitive abnormalities in schizophrenia Neuropsychopharmacology 31 2022 2032 10.1038/sj.npp.1301049 1:CAS:528:DC%2BD28XotFKksr4%3D 16554747 (Pubitemid 44246348)
17. PJ Harrison 1999 The neuropathology of schizophrenia: a critical review of the data and their interpretation Brain 122 593 624 10.1093/brain/122.4.593 10219775 (Pubitemid 29158770)
18. PJ Harrison SL Eastwood 2001 Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia Hippocampus 11 508 519 10.1002/hipo.1067 1:STN:280:DC%2BD3Mnos1ahtQ%3D%3D 11732704 (Pubitemid 33100372)
19. PJ Harrison DR Weinberger 2005 Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence Mol Psychiatry 10 1 40 68 10.1038/sj.mp.4001558 1:CAS:528:DC%2BD2cXhtFeisL3N 15263907 (Pubitemid 40139588)
20. K Hashimoto T Fukushima E Shimizu N Komatsu H Watanabe N Shinoda M Nakazato C Kumakiri S Okada H Hasegawa K Imai M Iyo 2003 Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia Arch Gen Psychiatry 60 572 576 10.1001/archpsyc.60.6.572 1:CAS:528:DC%2BD3sXltlKht74%3D 12796220 (Pubitemid 36682314)
21. K Hashimoto G Engberg E Shimizu C Nordin LH Lindstrom M Iyo 2005 Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients Prog Neuro psychopharmacol Biol Psychiatry 29 767 769 10.1016/j.pnpbp.2005.04.023 1:CAS:528:DC%2BD2MXlslymtbk%3D (Pubitemid 40897791)
22. S Heckers 2001 Neuroimaging studies of the hippocampus in schizophrenia Hippocampus 11 520 528 10.1002/hipo.1068 1:STN:280:DC%2BD3Mnos1ahug%3D%3D 11732705 (Pubitemid 33100373)
23. S Heckers C Konradi 2002 Hippocampal neurons in schizophrenia J Neural Transm 109 891 905 10.1007/s007020200073 1:CAS:528:DC%2BD38XmtVCqtr8%3D 12111476 (Pubitemid 34810781)
24. K Horiike H Tojo R Arai M Nozaki T Maeda 1994 d-Amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes Brain Res 652 297 303 10.1016/0006-8993(94)90240-2 1:CAS:528:DyaK2cXltVCqsbk%3D 7953743
25. T Jahn L Mussgay 1989 Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien: ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten Z Klin Psychol 18 257 267
26. PB Jones CJ Tarrant 1999 Specificity of developmental precursors to schizophrenia and affective disorders Schizophr Res 39 2 121 125 10.1016/S0920-9964(99)00110-3 1:STN:280:DyaK1MvjsFemtA%3D%3D 10507522 (Pubitemid 29415683)
27. R Kapoor KS Lim A Cheng T Garrick V Kapoor 2006 Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1) Brain Res 1106 1 205 210 10.1016/j.brainres.2006.05.082 1:CAS:528: DC%2BD28XotVCrt7k%3D 16828464 (Pubitemid 44177639)
28. JR Kelsoe MA Spence E Loetscher M Foguet AD Sadovnicki RA Remick P Flodman J Khristich Z Mroczkowski-Parker JL Brown D Masser S Ungerleider MH Rapaport WL Wishart H Luebbert 2001 A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22 Proc Natl Acad Sci USA 98 2 585 590 10.1073/pnas.011358498 1:CAS:528:DC%2BD3MXnslKguw%3D%3D 11149935 (Pubitemid 32105086)
29. DA Lewis P Levitt 2002 Schizophrenia as a disorder of neurodevelopment Annu Rev Neurosci 25 409 432 10.1146/annurev.neuro.25.112701.142754 1:CAS:528:DC%2BD38XmtF2hsbw%3D 12052915 (Pubitemid 34748023)
30. D Li L He 2007 G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies Genetics 175 917 922 10.1534/genetics.106. 061796 1:CAS:528:DC%2BD2sXkt1WgtL4%3D 17179078 (Pubitemid 46798286)
31. X Liu G Hea X Wanga Q Chena X Qiana W Lina D Lia N Guc G Fengc L Heb 2004 Association of DAAO with schizophrenia in the Chinese population Neurosci Lett 369 228 233 10.1016/j.neulet.2004.07.078 1:CAS:528:DC%2BD2cXotFShurw%3D 15464270 (Pubitemid 39298914)
32. C Madeira ME Freitas C Vargas-Lopes H Wolosker R Panizzutti 2008 Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia Schizophr Res 101 1-3 76 83 10.1016/j.schres.2008.02.002 18378121
33. G Molla S Sacchi M Bernasconi MS Pilone K Fukui L Pollegioni 2006 Characterization of human d-amino acid oxidase FEBS Lett 580 2358 2364 10.1016/j.febslet.2006.03.045 1:CAS:528:DC%2BD28Xjs1aisrs%3D 16616139
34. S Sacchi S Lorenzi G Molla MS Pilone C Rossetti L Pollegioni 2002 Engineering the substrate specificity of d-amino-acid oxidase J Biol Chem 277 27510 27516 10.1074/jbc.M203946200 1:CAS:528:DC%2BD38XlvV2hsrw%3D 12021281 (Pubitemid 34951772)
35. MJ Schell ME Molliver SH Snyder 1995 d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release Proc Natl Acad Sci USA 92 3948 3952 10.1073/pnas.92.9.3948 1:CAS:528:DyaK2MXlsVSks7k%3D 7732010
36. A Schmitt C Steyskal HG Bernstein T Schneider-Axmann E Parlapani EL Schaeffer WF Gattaz B Bogerts C Schmitz P Falkai 2009 Stereologic investigation of the posterior part of the hippocampus in schizophrenia Acta Neuropathol 117 395 407 10.1007/s00401-008-0430-y 18777029
37. J Schumacher R Abon Jamra J Freudenberg T Becker S Ohlraun ACJ otte M Tullius S Kovalenko A Van Den Bogaert W Maier M Rietschel P Propping MM Nöthen S Cichon 2004 Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder Mol Psychiatry 9 203 207 10.1038/sj.mp.4001421 1:CAS:528:DC%2BD2cXht1Sjtbs%3D 14966479 (Pubitemid 38299535)
38. J Shi ES Gershon C Liu 2008 Genetic associations with schizophrenia: meta-analyses of 12 candidate genes Schizophr Res 104 1-3 96 107 10.1016/j.schres.2008.06.016 18715757
39. L Verrall L Hutchinson P Harrison P Burnet 2006 d-amino acid oxidase and serine racemase expression in the dorso-lateral pre-frontal cortex in schizophrenia Int J Neuropsychopharmacol 9 143
40. DR Weinberger 1987 Implications of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiatry 44 660 669 1:STN:280:DyaL2s3ntVSksQ%3D%3D 3606332
41. H Wolosker S Blackshaw SH Snyder 1999 Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission Proc Natl Acad Sci USA 96 13409 13414 10.1073/pnas.96.23.13409 1:CAS:528:DyaK1MXns1Gmtb0%3D 10557334
42. LS Wood EH Pickering BM Dechaio 2007 Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia Biol Psychiatry 61 10 1195 1199 10.1016/j.biopsych.2006.07.005 1:CAS:528:DC%2BD2sXkvFOrurc%3D 17055463 (Pubitemid 46669455)
43. S Yang H Qiao L Wen W Zhou Y Zhang 2005 d-serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8 Neurosci Lett 379 1 7 12 10.1016/j.neulet.2004.12.033 1:CAS:528:DC%2BD2MXivF2jtr0%3D 15814189 (Pubitemid 40462388)
44. M Zink S Rapp P Gebicke-Haerter FA Henn J Thome 2005 Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus Psychopharmacology 181 560 565 10.1007/s00213-005-0017-4 1:CAS:528: DC%2BD2MXhtFemtb3K 15983795 (Pubitemid 41480905)